We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Gadolinium-Based Contrast Agents

    Gadolinium-based contrast agents (GBCA) have become an integral component of the cardiovascular magnetic resonance imaging (MRI) exam. GBCA are used...
    Chapter 2023
  2. Gadolinium-Based Contrast Agents

    This chapter reviews the neuroimaging features of the potential effects of gadolinium-based contrast agent use.
    Harut Haroyan, Daniel Thomas Ginat in Neuroimaging Pharmacopoeia
    Chapter 2022
  3. Late/delayed gadolinium enhancement in MRI after intravenous administration of extracellular gadolinium-based contrast agents: is it worth waiting?

    The acquisition of images minutes or even hours after intravenous extracellular gadolinium-based contrast agents (GBCA) administration (“Late/Delayed...

    Marco Parillo, Carlo Augusto Mallio, ... Carlo Cosimo Quattrocchi in Magnetic Resonance Materials in Physics, Biology and Medicine
    Article 22 February 2024
  4. Review of strategies to reduce the contamination of the water environment by gadolinium-based contrast agents

    Gadolinium-based contrast agents (GBCA) are essential for diagnostic MRI examinations. GBCA are only used in small quantities on a per-patient basis;...

    Helena M. Dekker, Gerard J. Stroomberg, ... Mathias Prokop in Insights into Imaging
    Article Open access 27 February 2024
  5. Contrast Agents

    Contrast agents are a heterogeneous group of pharmaceuticals used during radiological procedures to enhance tissue definition, enabling clearer...
    Chapter 2023
  6. The role of gadolinium-based contrast agents in magnetic resonance imaging structured reporting and data systems (RADS)

    Among the 28 reporting and data systems (RADS) available in the literature, we identified 15 RADS that can be used in Magnetic Resonance Imaging...

    Marco Parillo, Carlo Augusto Mallio, ... Carlo Cosimo Quattrocchi in Magnetic Resonance Materials in Physics, Biology and Medicine
    Article Open access 13 September 2023
  7. Comparison of the Pharmacokinetics of Gadolinium-Based and Iron Oxide-Based Contrast Agents inside the Lymphatic Structure using Magnetic Resonance Lymphangiography

    Purpose

    Gadolinium (Gd)-based contrast agents are primarily used for contrast-enhanced magnetic resonance lymphangiography (MRL). However, overcoming...

    Yeon Ji Chae, Kyung Won Kim, ... Dong-Cheol Woo in Molecular Imaging and Biology
    Article 29 April 2024
  8. Impact of gadolinium-based contrast agents on attenuation correction and tracer quantification in neuroendocrine malignancies in [68Ga]-DOTATOC PET/MRI

    Objectives

    To investigate the influence of Gadolinium-based contrast agents (CA) on MR-based attenuation correction (MRAC) in evaluating target...

    Aleksandar Milosevic, Michal Chodyla, ... Benedikt M. Schaarschmidt in Clinical and Translational Imaging
    Article 25 April 2024
  9. Use of gadolinium-based contrast agents in multiple sclerosis: a review by the ESMRMB-GREC and ESNR Multiple Sclerosis Working Group

    Abstract 

    Magnetic resonance imaging (MRI) is the most sensitive technique for detecting inflammatory demyelinating lesions in multiple sclerosis (MS)...

    Àlex Rovira, Fabio M. Doniselli, ... Carlo C. Quattrocchi in European Radiology
    Article 02 September 2023
  10. Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study

    Background

    We compared T1- and T2-weighted signal intensities of liver-specific (gadoxetate, gadobenate) and non-specific (gadoterate) gadolinium...

    Johannes M. Froehlich, Leen Moussa, ... Simon Matoori in European Radiology Experimental
    Article Open access 24 April 2023
  11. Spectral computed tomography angiography using a gadolinium-based contrast agent for imaging of pathologies of the aorta

    Objectives

    Especially patients with aortic aneurysms and multiple computed tomography angiographies (CTA) might show medical conditions which oppose...

    Markus Graf, Felix G. Gassert, ... Jonathan Nadjiri in The International Journal of Cardiovascular Imaging
    Article Open access 29 February 2024
  12. Gadolinium-Based Contrast Agent Safety with Focus on Kidney MRI

    Gadolinium-based contrast materials (GBCMs) are essential to the modern-day clinical practices of radiology and magnetic resonance imaging (MRI),...
    Jonathan R. Dillman in Advanced Clinical MRI of the Kidney
    Chapter 2023
  13. Safe and optimized use of gadolinium-based contrast agents in neuroimaging

    Àlex Rovira, Carlo C. Quattrocchi in European Radiology
    Article 25 November 2023
  14. Elemental bioimaging and transcriptomics reveal unchanged gene expression in mouse cerebellum following a single injection of Gadolinium-based contrast agents

    Gadolinium (Gd) deposition in the brain, first and foremost in the dentate nucleus in the cerebellum, following contrast enhanced MRI, rose awareness...

    Henning Richter, Anke Koke, ... Astrid Jeibmann in Scientific Reports
    Article Open access 26 April 2023
  15. Ultrasmall iron oxide nanoparticles and gadolinium-based contrast agents in magnetic resonance imaging: a systematic review and meta-analysis

    Background

    A comparison between the ultra-small iron oxide nanoparticles (US-IO) and commercial gadolinium-based contrast agents (Dotarem) as positive...

    Azadeh Amraee, Samideh Khoei, ... Ayuob Aghanejad in Clinical and Translational Imaging
    Article 15 October 2022
  16. Added value of gadolinium-based contrast agents for magnetic resonance evaluation of adnexal torsion in girls

    Purpose

    Ultrasound is the first-line imaging modality to evaluate adnexa in girls with clinical suspicion of torsion. Patients with equivocal...

    Mohamed M. Elsingergy, Edward R. Oliver, ... Susan J. Back in Abdominal Radiology
    Article 17 August 2022
  17. The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis

    Objective

    To determine whether reliable brain atrophy measures can be obtained from post-contrast 3D T1-weighted images in patients with multiple...

    Ingrid Anne Lie, Emma Kerklingh, ... Hugo Vrenken in European Radiology
    Article Open access 03 January 2022
  18. Variability in hair gadolinium concentrations among decedents who received gadolinium-based contrast agents

    This study utilized laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) to quantify gadolinium in the hair of autopsy cases that...

    Brianne R. Duncan, Makoto Hasegawa, ... Christopher D. Simpson in Analytical and Bioanalytical Chemistry
    Article 27 January 2021
  19. Nanomaterial-based contrast agents

    Medical imaging, which empowers the detection of physiological and pathological processes within living subjects, has a vital role in both...

    Jessica C. Hsu, Zhongmin Tang, ... David P. Cormode in Nature Reviews Methods Primers
    Article 13 April 2023
  20. Design and synthesis of chiral DOTA-based MRI contrast agents with remarkable relaxivities

    Due to the adverse effects of de-metallation in past concerning FDA-approved gadolinium-based contrast agents (GBCAs), researchers have been focusing...

    Junhui Zhang, Lixiong Dai, ... Ga-Lai Law in Communications Chemistry
    Article Open access 16 November 2023
Did you find what you were looking for? Share feedback.